ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008

Tobacco Research Council Awards Six New Grants

July 4, 1975

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

January 23, 1976

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

July 9, 1982